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There has been, however, a great deal of debate on exactly what research and experimentation activities (hereafter "research activities") should fall under such an exception.
In practice, the scope and coverage of the research exception have varied from country to country. This Policy Brief aims at examining the practice of countries with respect to the research exception and a related exception that has an impact on a specific type of research, the regulatory review ("Bolar") exception. After examining the practice of various jurisdictions, the Brief attempts to extract some lessons. The main objective of the Policy Brief is to suggest the possible parameters of policy interventions that may be adopted at the national and international level by countries that wish to codify exceptions for certain research activities in a manner that will make patent law work more effectively for innovation, better adapt to local technological conditions, and increase the benefits of the patent system for the society at large. The clause thus allows WTO Members to carve out exceptions to patent rights that meet the so-called "three-step test", i.e. that the exception: (1) is limited; (2) does not unreasonably conflict with normal exploitation; and (3) does not unreasonably prejudice the legitimate interests of the patent holder.
A broad exception for research and experimentation activities can be found in the legislation of a number of developing countries. The Brazilian Patent Act, for instance, exempts acts carried out by unauthorized third parties for experimental purposes, in connection with scientific or technological studies or research. 4 The Bangui Agreement establishing the Africa Industrial Property Organization (OAPI) provides that "the rights deriving from the patent shall not extend ... to acts in relation to a patented invention that are carried out for experimental purposes in the course of scientific and technical research." 5 In the absence of any further qualifying language, the language contained in these legal instruments would provide a safe harbor against patent infringement for practically all scientific and technological research activities.
Exceptions to Patents Rights at the International Level: The Research and Experimentation Exception
Jurisprudence, and legislation in a number of jurisdictions, shows that a research exception to patent rights has been recognized subject to some limitations. One way in which some jurisdictions have decided which research activities may or may not fall under the exception is by distinguishing between research and experimentation that is commercial and non-commercial.
In the United States (US), the scope of the research exemption has been governed by federal court decisions dating back to the 1813 Whittemore v. Cutter ruling that "it could never have been the intention of the legislature to punish a man, who constructed such a machine merely for philosophical experiments, or for the purpose of ascertaining the sufficiency of the machine to produce its described effects." 6 In the same year, Sawin v. Guild widened experimental use beyond machines and also introduced the concept of non-commercial use when the court excluded from infringement the exploitation of a patented invention unless it constituted "making with an intent to use for profit, and not for the mere purpose of philosophical experiment, or to ascertain the verity and exactness of the specification." 7 Forty-eight years later (Peppenhausen v. Falke) it was "held, and no doubt is now
Commercial vs. Non-Commercial Research
The research and experimentation exceptions in patent law: 19 The case law in developed nations is not sufficiently developed to explain the applicability of the research exemption for research "with" a patented product, and other research tool patents. 
Lessons from the Jurisdictional Variation in the Research and Experimentation Exceptions in Patent Law
to prevent the "making" and "using" of the protected product. In contrast, the regulatory approval exception is In practice, however, it is becoming increasingly difficult to make such a distinction. In the US, for instance, the trend has been for courts to narrow the exception, since much scientific research could be said to have some commercial aspect, as in the case of research conducted by universities (i.e., the Madey case).
The legal and jurisprudential development on the application of the research exception to research activities "with" the patented subject matter is more demanding. For example, the Swiss patent law advanced In view of the above, the important lesson from these examples is that, while practically all countries recognize that there ought to be a research exception, the commercial/non-commercial distinction has paved the way for courts to narrow the scope of the exception, at least in certain common law jurisdictions. A broad exception covering all scientific and technological research activities would appear to be one way to preserve a wide exception, while the Swiss approach, distinguishing between research "with" and research "on" the patent, could be considered as a middle ground between a broad exception covering all research activities and the very limited exception The research exception is one of the important • exceptions to patent rights that has long been recognized in the patent laws of developed and developing countries alike.
A research exception grounded upon the com-• mercial/non-commercial distinction appears to be less workable as it has become increasingly difficult to distinguish research that is commercial and research that is noncommerical. Deciding what research falls under the exception based on the commercial/ non-commercial character of the research has paved the way for courts to narrow the scope of the exception, at least in certain common law (and even some statutory) jurisdictions.
The WHO's 2008 Global Strategy and Plan • of Action on Public Health, Innovation and Intellectual Property specifically recognizes that a research exception could help to address public health needs in developing countries. In this context, further examination might be called for to consider the extent to which a robust research exception could encourage much-needed research into neglected diseases.
Unlike the research exception, the regulatory • review exception, also known as the "Bolar" exception, is firmly grounded in WTO case law. This exception permits clinical trials and other preparatory activities "on" or "with" a patented pharmaceutical product prior to the expiry of the patent so as to enable generic competitors to file an application for marketing approval of the competing product(s) as soon as possible after the expiry of the patent. 
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